Vaccinating donors to improve GVL

Blood

Volumn 118, Issue 22, 2011, Pages 5720-5721

  Hill, Geoffrey R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOLOGICAL ADJUVANT; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; DONOR; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNITY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NOTE; PATHOGEN SPECIFIC IMMUNITY; PRIORITY JOURNAL; T CELL DEPLETION; VACCINATION;

EID: 82155184608     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-381160     Document Type: Note

References (6)

1. Li N, Matte-Martone C, Zheng H, et al. Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improves GVL and immune reconstitution. Blood. 2011;118(22):5965-5976.
2. Savoldo B, Ramos CA, Liu E, et al. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 2011;121(5):1822-1826.
3. Hudecek M, Schmitt TM, Baskar S, et al. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood. 2010;116(22):4532-4541.
4. Micklethwaite KP, Savoldo B, Hanley PJ, et al. Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation. Blood. 2010;115(13):2695-2703.
5. Bleakley M, Riddell SR. Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol. 2011;89(3):396-407.
6. Warren EH, Fujii N, Akatsuka Y, et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood. 2010;115(19):3869-3878.